Combining structure-based drug design and pharmacophores

Area of Science:

• Structural biology
• Computational chemistry
• Drug discovery

Background:

• Integrated computer-aided drug design (CADD) methodologies are crucial for efficient drug discovery.
• Structure-based pharmacophores offer a detailed representation of ligand-target interactions.
• Utilizing crystal structure complexes provides valuable insights into binding site characteristics.

Purpose of the Study:

• To develop and present novel structure-based pharmacophore generation methods.
• To define and compare different types of pharmacophores derived from protein-ligand complexes.
• To demonstrate the application of these novel pharmacophores in database searching for drug discovery.

Main Methods:

• Generation of structure-based pharmacophores from protein-ligand crystal structures.
• Analysis of ligand features, protein interactions, and binding site space.
• Comparison of various pharmacophore types using HIV-1 reverse transcriptase (RT) as a model target.
• Application of pharmacophores in virtual screening and database searching.

Main Results:

• Novel pharmacophores were generated, capturing ligand-protein interactions and binding site topology.
• The concept of a 'superligand' was introduced, equivalent to a pharmacophore, integrating interaction and spatial information.
• HIV-1 RT was used as a case study to illustrate the utility of the developed pharmacophores.
• The effectiveness of these pharmacophores in database searching was demonstrated.

Conclusions:

• Structure-based pharmacophores derived from crystal complexes represent a powerful tool for CADD.
• These pharmacophores provide a comprehensive description of potential ligand interactions and binding site properties.
• The presented methodology facilitates the identification of novel drug candidates through enhanced database searching.